Condition
Cutaneous Squamous Cell Cancer
Total Trials
5
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Early P 1 (1)
P 1 (2)
P 2 (1)
Trial Status
Recruiting4
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07217171Phase 1Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
NCT04389632Phase 1Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT07384949Not Yet RecruitingPrimary
Correlation of Dermoscopic Findings With Histopathological Features and Invasion Depth in Cutaneous Squamous Cell Carcinoma
NCT06664151Early Phase 1Recruiting
A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
NCT06823479Phase 2Recruiting
Towards Cure Via Only Ultra-short ICB in CSCC
Showing all 5 trials